News Focus
News Focus
icon url

Karlchen

01/25/21 6:08 PM

#142786 RE: kgromax #142765

if that s the case, whats up? who cares? Aah, CARES ! ?
Standard of CAREs = placebo arm = THE SAME PEOPLE, if they ever took cheries, if they ever choosed just people who seemed to be easy for the trail - EXCACT these people are in the treatment AS WELL AS in the placebo arm ! What advantage has the " fake " CYDY company. Placebo arm wood do extremely well too, and the treatment arm would do just slightly better!. Or in other words, the difference would be THE SAME ! (bad, not big enough) We must have a big difference between placebo/treatment and that difference you get with very sick people (in both arms) or in cherry picked covid patients with all mild symptoms! ?
enough said!
icon url

lostmyballs

01/25/21 8:14 PM

#142800 RE: kgromax #142765

This reasoning is off . . Man someone is really confused . And so wrong . Did really really write this .

“”It is not possible that they are in a worse shape because...Cytodyn excludes the ones with a worse shape!
As I have shown in my post, patients with a high respiratory distress, typical of nearly 60% of ICUs patients, are excluded by Cytodyn. They only keep the « mild » critical cases. That puts a ceiling on the mortality rate. Even if ALL patients were at this ceiling (which is not possible either but for the sake of it let’s just imagine), the primary endpoint would still not be statistically significant. It’s game over...””